CBD Clinical Trials Continue To Point Towards Success

CARLYS-LAWIt’s been over a year since the House of Representatives approved Carly’s Law in Alabama. This bill allowed testing of cannabidiol for treatment of children with severe seizures. Since the passage of this law, some of Alabama’s severest epilepsy patients gained access to clinical trials and began using the the oil. Although it’s only been 6 months into trials, promising results are emerging as doctors are pleased with what they are observing.

Melanie Posey reports on the condition of Carly Chandler from Birmingham, Alabama. Before being selected to take part in this clinical trial, 4 year old Chandler could barely move or perform basic motor skills. Posey reports that Chandler is now able to do so now after six months of using CBD oil, but she’s not alone. […]

One Girl Leads The Battle For Medical Marijuana In Mexico

mexico flag mapIn Mexico City, 8 year old Graciela Elizalde lives with a rare disease that makes her suffer from up to 400 epileptic convulsions every day. Despite having to endure surgery and seeking out alternative treatments, her epileptic fits “have greatly grown in intensity, force, and frequency” her mother said. Grace’s parents were losing hope in finding relief for their daughter until they learned about a child in the US state of Colorado whose epilepsy improved thanks to cannabidiol.

Despite Mexico’s prohibition, Grace’s parents sought out a permit from the health ministry, which was rejected. The family was forced to hire an attorney, who then took their case to court. On Aug. 17, Judge Martin Santos ruled on this case, extending legal protection to authorities who permit Graciela Elizalde’s parents to import a medicine containing cannabidiol, a substance banned by Mexico’s General Law of Health. While Grace doesn’t know it, this case is making history in Mexico.  […]

International Relations: Cannabis & CBD Oil Continues To Find Support

Dr. Nora Volkow,

Dr. Nora Volkow, director of the National Institute on Drug Abuse in Bethesda, Md.

Dr. Nora Volkow, director of the National Institute on Drug Abuse, recently stepped forward to help clarify some of the misinformation circling marijuana and cannabidiol. As one of the world’s top experts on the application and misuse of cannabis and research, Volkow believes “what we can say with certainty is that cannabis contains active ingredients with potential therapeutic properties. In fact, the FDA has already approved medicines based on THC for the treatment of wasting syndrome and to control nausea in chemotherapy patients.”

While it may be a surprise to some that the FDA has actually approved products recognizing some of the positive aspects of THC, what shouldn’t come as a surprise is the support behind cannabidiol (CBD).

“There is also a great deal of interest in developing medications based on another constituent of the cannabis plant called cannabidiol” Volkow believes. “CBD, which does not give users the classic ‘high,’ has shown some promise in controlling seizures in children with severe forms of epilepsy (including Dravet and Lennox-Gastaut syndromes), and preliminary trials of a CBD-based drug are underway by GW Pharmaceuticals. There are likely many more applications for these other cannabinoids that are supported by a scientific rationale and some intriguing preliminary results that warrant more research.” […]

CBD Added As Effective Autism Treatment In Michigan As Support Grows In Congress

Michigan State Senate - Michigan’s Medical Marijuana Review Panel voted to add autism to the list of conditions that qualifies a patient for medical marijuana

Michigan State Senate – Michigan’s Medical Marijuana Review Panel voted to add autism to the list of conditions that qualifies a patient for medical marijuana

Last Friday, Michigan’s Medical Marijuana Review Panel voted to add autism to the list of qualifying conditions fit for treatment under state law.

Mike Zimmer, director of the Michigan Department of Licensing and Regulatory Affairs, is the next step in the process for approval. Zimmer has until late October to make a final decision. Once a final determination is made it will be announced on the agency’s website.

Supporters say using high CBD oil has been shown to help patients who suffer from severe autism, and added that the marijuana would not be given to patients in smokeable form.

The panel in charge of making this decision had the opportunity to listen to comments from some Detroit-area doctors, most notably the head of pediatric neurology at Children’s Hospital of Michigan. They also heard from fed up parents, desperate to find relief for their children.

“The parents I’ve talked to are passionate and adamant that this represents a dramatic improvement in the quality of life for them and their affected children,” said David Crocker, a medical marijuana doctor and member of the panel.

Michigan Lt. Gov. Brian Calley, whose daughter Reagan has autism, has been an advocate of the effort to add autism to the list. […]

Veterans With PTSD Continue To Face Barriers To Alternative Treatments

Veteran AffairsIn the U.S. military, the U.S. Department of Veterans Affairs estimates that in Operations Iraqi Freedom and Enduring Freedom, about 11-20 out of every 100 Veterans (or between 11-20%) who served in these operations have PTSD in a given year. Additionally, about 12 out of every 100 Gulf War Veterans (or 12%) have PTSD in a given year.

Post-traumatic stress disorder (PTSD) can occur after you have been through any significant trauma. A trauma is an alarming and often terrifying event that you see or experience. Going through trauma is not rare, although only a small portion of people who have experienced trauma actually develop PTSD. It is estimated that about 8 million adults have PTSD in a given year.

While PTSD is a severe mental health condition, there is currently an insufficient emphasis on effective medications for PTSD patients. Additionally, the medications that are currently recommended for PTSD provide limited efficacy. […]

Breaking Down The Barriers To CBD Support

U.S. Sen. Dianne Feinstein (D-CA) (R) and U.S. Sen. Chuck Grassley (R-IA) talk during Senate Caucus on International Narcotics Control hearing on Capitol Hill (Photo by Mark Wilson/Getty Images)

U.S. Sen. Dianne Feinstein (D-CA) (R) and U.S. Sen. Chuck Grassley (R-IA) talk during Senate Caucus on International Narcotics Control hearing on Capitol Hill (Photo by Mark Wilson/Getty Images)

Over the past few months, from local community halls to Capitol Hill, one thing has been made clear: there is an outcry of support in favor of more research on CBD and medical marijuana. Proponents of CBD oil state that removing these barriers to research is the only clear way to market something so significant to families around the world.

Earlier this year, Democrat Sen. Diane Feinstein (CA) and Republican Sen. Charles Grassley (IA) urged the Obama administration to “definitively determine if CBD has scientific and medical benefits,” and to “look at expanding compassionate access programs where possible, to benefit as many children as possible.”

Recently, support has also come out from the director of the US National Institute on Drug Abuse (NIDA), Nora Volkow. Volkow believes that cannabidiol (CBD) – a nonpsychotropic cannabinoid – is “a safe drug with no addictive effects.” In a column with The Huffington Post, she further stated that“[P]reliminary data suggest that it may have therapeutic value for a number of medical conditions.”

With all of the talk going on around the country, is there any action behind these promises? […]